Organizer: VIB Conferences

Host institution: VIB, Ghent University, Cell Press

Start: Thursday, 21 February 2019 @ 08:00

End: Friday, 22 February 2019 @ 18:00

Sponsors: Vector Builder

Contact: confferences@vib.be

Venue: OLD ST. JOHN SITE, Zonnekemeers

City: Brugge

County: West-Vlaanderen

Country: Belgium

Postcode: 8000

Description:

Type 2 inflammation rich in eosinophils, basophils and mast cells and orchestrated by Th2 lymphocytes has been mainly studied in the context of allergies and immune responses to helminths. Since the discovery of type 2 innate lymphoid cells there has been a strong interest in understanding how type 2 immunity is induced and regulated, for example by barrier epithelial cells.

Given the recent introduction of new biologics that target type 2 cytokines to treat severe allergic disease, we are accumulating a lot of new insights on type 2 immune responses in humans as well.

This meeting will not only focus on new effector and regulatory mechanisms of the type 2 immune response. It will also offer a number of talks taking a broader look on type 2 immunity, dealing with such topics as type 2 immunity in homeostasis, growth and repair, metabolism, neuro-immune interactions and cancer.

Understanding these alternative roles for type 2 immunity will be important to address the benefits and potential pitfalls of long-term inhibition of type 2 immunity by biologicals and could elucidate new therapeutic pathways for very common diseases like asthma, obesity, diabetes and cancer.

Abstracts can be submitted for the following topics:

Tissue homeostasis and repair
Type 2 Neuro-immune axis
Type 2 in allergy, asthma & helminth infection
Type 2 Immunity & Cancer

Deadlines:
• Early Bird: 10 January 2019
• Late Registration: 7 February 2019
• Abstract deadline: 19 December 2018

Event type:
  • Meetings and conferences

Keywords: Immunity, Cancer, Cancer Biomarkers, Cancer Biomarkers in Clinical Use, Types of Biomarker and Biomarkers, Surgical oncology, Pediatric Oncology, Haematologist-oncology, Gynecologist oncology, Orthopaedic Oncology, Breast Cancer, Neuro-oncology, Pathophysiology of Cancer, Cancer Pharmacology, Cancer Therapeutics, Homeopathy Cancer Treatment Cancer Epigenetics, Cancer: Lifestyle and Nutrition, Cancer Prognosis and Predictive Factor, Cancer Proteomics, Molecular Epidemiology of Cancer, Cancer Nursing and Care, Cancer Diagnosis, Cancer Biopsy, Magnetic Resonance Imaging (MRI),Factors Associated with Cancer Prevalence, Cancer Pharma Industry, Economic Impact on Cancer, Allergy, Asthma, Type 2 immunity

Type 2 Immunity in Homeostasis and Disease https://tess.elixir-europe.org/events/type-2-immunity-in-homeostasis-and-disease Type 2 inflammation rich in eosinophils, basophils and mast cells and orchestrated by Th2 lymphocytes has been mainly studied in the context of allergies and immune responses to helminths. Since the discovery of type 2 innate lymphoid cells there has been a strong interest in understanding how type 2 immunity is induced and regulated, for example by barrier epithelial cells. Given the recent introduction of new biologics that target type 2 cytokines to treat severe allergic disease, we are accumulating a lot of new insights on type 2 immune responses in humans as well. This meeting will not only focus on new effector and regulatory mechanisms of the type 2 immune response. It will also offer a number of talks taking a broader look on type 2 immunity, dealing with such topics as type 2 immunity in homeostasis, growth and repair, metabolism, neuro-immune interactions and cancer. Understanding these alternative roles for type 2 immunity will be important to address the benefits and potential pitfalls of long-term inhibition of type 2 immunity by biologicals and could elucidate new therapeutic pathways for very common diseases like asthma, obesity, diabetes and cancer. Abstracts can be submitted for the following topics: Tissue homeostasis and repair Type 2 Neuro-immune axis Type 2 in allergy, asthma & helminth infection Type 2 Immunity & Cancer Deadlines: • Early Bird: 10 January 2019 • Late Registration: 7 February 2019 • Abstract deadline: 19 December 2018 2019-02-21 08:00:00 UTC 2019-02-22 18:00:00 UTC VIB Conferences OLD ST. JOHN SITE, Zonnekemeers, Brugge, Belgium OLD ST. JOHN SITE, Zonnekemeers Brugge West-Vlaanderen Belgium 8000 VIBGhent UniversityCell Press confferences@vib.be Vector Builder [] meetings_and_conferences [] ImmunityCancer, Cancer Biomarkers, Cancer Biomarkers in Clinical Use, Types of Biomarker and Biomarkers, Surgical oncology, Pediatric Oncology, Haematologist-oncology, Gynecologist oncology, Orthopaedic Oncology, Breast Cancer, Neuro-oncology, Pathophysiology of Cancer, Cancer Pharmacology, Cancer Therapeutics, Homeopathy Cancer Treatment Cancer Epigenetics, Cancer: Lifestyle and Nutrition, Cancer Prognosis and Predictive Factor, Cancer Proteomics, Molecular Epidemiology of Cancer, Cancer Nursing and Care, Cancer Diagnosis, Cancer Biopsy, Magnetic Resonance Imaging (MRI),Factors Associated with Cancer Prevalence, Cancer Pharma Industry, Economic Impact on CancerAllergyAsthmaType 2 immunity